|
RECK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.356600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24759999997615E-06 |
| Normal-vs-Stage2 |
3.550300E-02 |
| Normal-vs-Stage3 |
1.653030E-01 |
| Normal-vs-Stage4 |
8.035600E-03 |
| Stage1-vs-Stage2 |
2.350400E-01 |
| Stage1-vs-Stage3 |
1.148450E-01 |
| Stage1-vs-Stage4 |
9.885400E-01 |
| Stage2-vs-Stage3 |
6.342200E-01 |
| Stage2-vs-Stage4 |
5.131600E-01 |
| Stage3-vs-Stage4 |
3.386200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.780690E-04 |
| Normal-vs-AfricanAmerican |
1.257570E-03 |
| Normal-vs-Asian |
1.862610E-01 |
| Caucasian-vs-AfricanAmerican |
9.348800E-01 |
| Caucasian-vs-Asian |
6.519000E-01 |
| AfricanAmerican-vs-Asian |
6.626800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58049999976484E-07 |
| Normal-vs-Female |
1.808820E-01 |
| Male-vs-Female |
7.573600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.185600E-04 |
| Normal-vs-Extreme_Weight |
6.16310000000064E-05 |
| Normal-vs-Obese |
3.338000E-03 |
| Normal-vs-Extreme_Obese |
6.441800E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.984400E-01 |
| Normal_Weight-vs-Obese |
7.200600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.069200E-01 |
| Extreme_Weight-vs-Obese |
2.641800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.107800E-01 |
| Obese-vs-Extreme_Obese |
1.826360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.812400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.676900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.15240000045469E-07 |
| Normal-vs-Age(81-100Yrs) |
6.290000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.301190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.939600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.974410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.101880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.914000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.826770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.83718999999805E-05 |
| Normal-VS-Type2 PRCC |
4.86379999609099E-08 |
| Normal-VS-KIRP CIMP |
1.065990E-01 |
| Normal-VS-Unclassified PRCC |
2.032600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.443600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.246050E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.315900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.359100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.521100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.081600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.20829999999506E-05 |
| Normal-vs-N1 |
2.619200E-01 |
| Normal-vs-N2 |
1.493430E-01 |
| N0-vs-N1 |
1.217830E-01 |
| N0-vs-N2 |
6.219400E-01 |
| N1-vs-N2 |
7.142600E-01 |
|
|
